InDevR Delivers Commercial Multiplex Coronavirus SeroAssay Kit and Testing Services for Vaccine Development
Boulder, CO – June 17, 2020– InDevR, Inc., a leader [...]
InDevR Raises $7 million in Series A Financing with Adjuvant Capital
Boulder, CO, 10 September 2019 – InDevR, Inc., a biotechnology [...]
Clinical validation of the FluChip-8G Influenza A+B Assay for influenza type and subtype identification published in Journal of Clinical Virology
Clinical validation of the FluChip-8G Influenza A+B Assay for influenza [...]
Analytical Evaluation of the Microarray-Based FluChip-8G Influenza A+B Assay published in Journal of Virological Methods
Analytical Evaluation of the Microarray-Based FluChip-8G Influenza A+B Assay published [...]
ASM Microbe 2019
InDevR will be present at the ASM conference in [...]
